Mechanism and therapeutic strategy of secondary failure to anti-tumor necrosis factor-α monoclonal antibody treatment for Crohn's disease.
about
The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatmentClinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel DiseaseUse of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it?Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.
P2860
Mechanism and therapeutic strategy of secondary failure to anti-tumor necrosis factor-α monoclonal antibody treatment for Crohn's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanism and therapeutic stra ...... treatment for Crohn's disease.
@en
type
label
Mechanism and therapeutic stra ...... treatment for Crohn's disease.
@en
prefLabel
Mechanism and therapeutic stra ...... treatment for Crohn's disease.
@en
P2860
P356
P1433
P1476
Mechanism and therapeutic stra ...... treatment for Crohn's disease.
@en
P2093
Katsuyoshi Matsuoka
Takanori Kanai
P2860
P356
10.1159/000351386
P577
2013-06-20T00:00:00Z